HUP1700236A2 - New polymorph and solvate of idelalisib - Google Patents
New polymorph and solvate of idelalisibInfo
- Publication number
- HUP1700236A2 HUP1700236A2 HUP1700236A HUP1700236A2 HU P1700236 A2 HUP1700236 A2 HU P1700236A2 HU P1700236 A HUP1700236 A HU P1700236A HU P1700236 A2 HUP1700236 A2 HU P1700236A2
- Authority
- HU
- Hungary
- Prior art keywords
- idelalisib
- solvate
- new polymorph
- polymorph
- new
- Prior art date
Links
- YKLIKGKUANLGSB-HNNXBMFYSA-N idelalisib Chemical compound C1([C@@H](NC=2[C]3N=CN=C3N=CN=2)CC)=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1 YKLIKGKUANLGSB-HNNXBMFYSA-N 0.000 title 1
- 229960003445 idelalisib Drugs 0.000 title 1
- 239000012453 solvate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1700236 HUP1700236A2 (en) | 2017-06-01 | 2017-06-01 | New polymorph and solvate of idelalisib |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1700236 HUP1700236A2 (en) | 2017-06-01 | 2017-06-01 | New polymorph and solvate of idelalisib |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP1700236A2 true HUP1700236A2 (en) | 2018-12-28 |
Family
ID=89992455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUP1700236 HUP1700236A2 (en) | 2017-06-01 | 2017-06-01 | New polymorph and solvate of idelalisib |
Country Status (1)
Country | Link |
---|---|
HU (1) | HUP1700236A2 (en) |
-
2017
- 2017-06-01 HU HUP1700236 patent/HUP1700236A2/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286316A (en) | Novel micro-dystrophins and related methods of use | |
GB2582482B (en) | CASZ compositions and methods of use | |
ZA201905677B (en) | Glycan-interacting compounds and methods of use | |
HK1256634A1 (en) | Pyrazole compounds and methods of making and using same | |
IL268305A (en) | Method of reducing neutropenia | |
GB2582100B (en) | CAS12C Compositions and methods of use | |
HK1253049A1 (en) | Glycan-interacting compounds and methods of use | |
IL263050B (en) | Derivatives of sobetirome | |
IL292244A (en) | Polymorphic forms of sodium benzoate and uses thereof | |
EP3094346A4 (en) | Vista antagonist and methods of use | |
IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
GB201609786D0 (en) | Compounds and method of use | |
ZA201906169B (en) | Synthekine compositions and methods of use | |
IL271543A (en) | Morphic forms of git38 and methods of manufacture thereof | |
IL272697A (en) | Polymorphic form of tg02 | |
IL292245A (en) | Polymorphic forms of rad1901-2hcl | |
IL276592A (en) | Derivatives of sobetirome | |
GB201708457D0 (en) | Inhibitors of metallo-beta-lactamases | |
EP3894768C0 (en) | Methods of cryo-curing | |
EP3448375C0 (en) | Benzoylglycine derivatives and methods of making and using same | |
PL3449931T3 (en) | Use of cerebrolysin | |
GB201708451D0 (en) | Inhibitors of metallo-beta-lactamases | |
IL283703A (en) | Polymorphic form of meisoindigo and modified formulation of meisoindigo | |
SG11202105136WA (en) | Application of chidamide | |
IL263363A (en) | Polymorph of nintedanib |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC4A | Lapse of provisional application due to refusal |